Clinical Trial

Molecular Landscape of Microvascular Inflammation in Kidney Allografts

Recruiting
View on ClinicalTrials.gov →
Summary
Microvascular inflammation in kidney allografts has been widely reappraised in the recent update of Banff classification. There is a critical need to better understand the pathophysiological mechanisms associated with the various phenotypes of microvascular inflammation that are observed in kidney transplants, particularly in order to develop targeted therapeutic approaches.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-03-26; most recent amendment 2025-05-27.
Trial Details
NCT Number NCT06342128
Lead Sponsor Paris Translational Research Center for Organ Transplantation
Conditions Kidney Rejection Transplant
Enrollment 600 participants
Start Date 2022-01-01
Primary Completion 2024-06-01 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-31